Mutations of TP53 gene commonly coexist with 17p deletions; however, their sole presence (4.5 % CLL patients) typifies poor survival similar to sole 17p deletions and bi-allelic TP53 alterations [18]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.